Sanofi, GSK Delay Covid Vaccine as Effectiveness Falls Short

Sanofi and GlaxoSmithKline Plc said they need to study if a retooled version of their Covid-19 vaccine candidate can produce better results among older people, delaying its potential availability to the end of next year.